Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgrastim in Acute Respiratory Failure (HBP Substudy)
NCT01713309Phase 3Completed
- Sponsor
- Helsinki University Hospital
- Start
- Jan 1996
- Primary completion
- Jun 1998
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute respiratory failure (ARF) comparing Filgrastim with Placebo (2 arms). Primary endpoint: Number of adverse events at 28 days. Started Jan 1996; status: completed.
02
Drugs
filgrastim
03
Conditions
acute respiratory failure (ARF)
Beyond the preview
Go deeper on NCT01713309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01713309.